FINWIRES · TerminalLIVE
FINWIRES

Rimbaco、株式75%売却後に強制買収提案に直面。株価は23%下落。

By

-- Rimbaco Group Global (HKG:1953)は、経営権の変更に伴い、無条件の強制現金買付の対象となった。

同社の株価は月曜午前の取引で23%以上下落した。

同社は、発行済株式資本の75%にあたる9億4500万株を1株あたり0.167香港ドル、総額約1億5750万香港ドルで売却したとの通知を受けたと発表し、これらの株式はRBC Ventureから Aureole Haloに売却された。

提出書類によると、1株あたり0.167香港ドルの買付価格は、前日終値から約74.3%の割引となる。

取引完了後、Aureole Haloは、Rimbaco の残りの全株式に対し、1株あたり0.167香港ドルの同価格で無条件の強制現金買付を行う義務を負う。

Rimbaco は、提示された買収案が公正かつ妥当であるかどうかを評価するために、独立した財務アドバイザーを任命すると述べた。

Related Articles

Mining & Metals

MediPharm Labs Says "Welcomes" Implementation of U.S. Final Order Cannabis Rescheduling

MediPharm Labs (LABS.TO) "welcomes" the implementation of the U.S. final order rescheduling certain cannabis products from Schedule I to Schedule III of the Controlled Substances Act, it said Monday.The order, which took effect April 22, recognizes the medical use of cannabis and is anticipated to materially reduce barriers to U.S. clinical research and pharmaceutical development, the company noted."The order is expected to accelerate U.S. research by enabling access to standardized medical-grade cannabis from registered suppliers," said the company in a statement. "For MediPharm Labs, this could mean an expanded pipeline of U.S. researchers and pharmaceutical companies advancing clinical trials and evaluating compliant active pharmaceutical ingredient ("API") suppliers."The order also "creates a clearer regulatory pathway" for FDA-approved drug products containing cannabis, which is directly aligned with MediPharm Labs pharmaceutical manufacturing strategy, it said.Shares of the company were last seen up $0.01 to $0.07 on the Toronto Stock Exchange.Price: $0.08, Change: $+0.01, Percent Change: +15.38%

$LABS.TO
Commodities

EU Sees Stable Gas Supply, Monitors Oil Markets Amid Hormuz Risks

European Union officials said gas storage remains near targets with 80% seen as sufficient for winter, while oil markets face risks from Hormuz disruptions, the European Commission said Friday.Experts from the European Commission, EU countries, and the International Energy Agency met to assess supply security as the Middle East conflict entered its third month.The Gas Coordination Group said supply conditions remain stable, with storage levels only slightly below pre-crisis averages despite ongoing geopolitical tensions.Officials said reaching 80% storage by the end of summer would adequately secure winter demand, according to the commission.EU countries are balancing storage refilling with economic considerations and have not introduced additional interventions so far, it said.Countries can activate regulatory flexibility in a timely manner if they fail to meet storage targets under EU legislation, officials said.The Oil Coordination Group is implementing actions under the April 22 AccelerateEU plan and introducing a Fuel Observatory to track supply, stocks, imports, and exports, the Commission said.Energy ministers mandated the European Commission at the extraordinary Transport, Telecommunications and Energy Council meeting on March 31 to collect national data on stocks and market conditions.The European Commission is using the collected data to build an EU-wide regional assessment of supply conditions and market developments, it said.Current data shows jet fuel supplies can meet demand, but a prolonged Strait of Hormuz closure could disrupt markets in the coming weeks and months, the Commission added.The European Commission will use the collected data to guide coordinated EU actions, including potential stock releases already committed under the IEA's collective response framework, it said.The European Commission will keep assessing impacts, coordinate actions, and stay in close contact with EU countries, the IEA, and market participants, the Commission added.

Research

Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Advanced Micro Devices

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price to $400 from $300, on a P/E of 27.6x and shifting to our 2028 EPS, which we start at $14.50, reflecting upside to EPS estimates. We boost our 2026 EPS to $6.71 from $6.55 and 2027 to $11.09 from $10.18. We are growing more optimistic about opportunities tied to CPU server demand, fueled by AMD's EPYC processors and growing content share as CPU-to-GPU ratios shift from 1:8 in training workloads to 1:1 or better in agentic AI deployments. Extending lead times and emerging industry-wide CPU shortage should support higher prices, and we see potential for 50%+ server CPU market share over time (from ~40% in late 2025). AMD's shift to large-scale rack-scale systems remains its biggest opportunity in the coming years. We are also encouraged by recent customer orders from Meta and Oracle, as we see a long tail opportunity over the next three to five years. Higher component prices (e.g., memory) and tight capacity at Taiwan Semi will need to be closely monitored and are potential risks.

$AMD